For the Inventor, By the Inventor

Enter assignee name

Institut Pasteur

USPTO Granted Patents = 898

% Expired Patents = 28.3

CIPO Patents = 35

EPO Patents = 241

Trademarks = 3

Forward Citations = 6,556

Loading Chart...

Loading Chart...

1,291 inventors (with patents filed for the assignee):

Luc Montagnier (91 out of 112 patents)

Marc Alizon (53 out of 62 patents)

Pierre Sonigo (52 out of 63 patents)

4. Frédéric Tangy (36 out of 36 patents)

5. Pierre Charneau (35 out of 36 patents)

6. Philippe Despres (34 out of 36 patents)

7. Denise Guetard (32 out of 33 patents)

8. Francois Clavel (31 out of 34 patents)

9. Simon Wain-Hobson (28 out of 41 patents)

10. Mireille Guyader (27 out of 27 patents)

11. Brigitte Gicquel (26 out of 27 patents)

12. Stewart T Cole (25 out of 27 patents)

13. Claude Leclerc (24 out of 25 patents)

14. Pierre Druilhe (24 out of 25 patents)

15. Jean-Luc Guesdon (22 out of 24 patents)

Core Competencies:

Nucleic Acid Vaccine

SARS-CoV-2

Malaria Antigens

Measles Virus

Immunogenic Composition

Antibody Neutralization

Peptide Inhibitors

Biological Diagnostics

Bacteriophage Therapy

Gene Therapy

Vector Delivery

Microfluidic Devices

898 patents: Sort by Forward Citations

1. 12753245 - LUCIFERASE LINKED IMMUNOSORBENT ASSAY (2026-10-06),

2. 12620100 - Method for detecting spatial coupling (2026-05-05),

3. 12612411 - Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins (2026-04-28),

4. 12606587 - Protected tetrasaccharides, their process of preparation and their use as transglucosylase acceptor substrates in the chemo-enzymatic synthesis ofspecific oligosaccharides (2026-04-21),

5. 12576164 - Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins (2026-03-17),

6. 12567481 - METHOD, DEVICE, AND COMPUTER PROGRAM FOR GENERATING PROTEIN SEQUENCES WITH AUTOREGRESSIVE NEURAL NETWORKS (2026-03-03),

7. 12533404 - COMPOSITIONS AND METHODS COMPRISING MEASLES VIRUS DEFECTIVE INTERFERING PARTICLES FOR THE PREVENTION OF INFECTIOUS DISEASES (2026-01-27),

8. 12529114 - A NOVEL ORTHOBUNYAVIRUS IN HUMAN ENCEPHALITIS AND ITS DIAGNOSTIC AND THERAPEUTIC APPLICATONS (2026-01-20),

9. 12521428 - Malaria pre-erythrocytic antigens as a fusion polypeptide and their use in the elicitation of a protective immune response in a host (2026-01-13),

10. 12516302 - DNA POLYMERASE THETA MUTANTS, METHODS OF PRODUCING THESE MUTANTS, AND THEIR USES (2026-01-06),

11. 12505543 - Method for identifying abnormalities in cells of interest in a biological sample (2025-12-23),

12. 12478652 - BACTERIOPHAGE THERAPY (2025-11-25),

13. 12473581 - Multiplexable microfluidic culture chamber for imaging monolayer growth of single cells (2025-11-18),

14. 12448412 - Antigenic tripeptides derived fromsubsp.S-type strains, derivatives and uses thereof (2025-10-21),

15. 12326451 - Severe acute respiratory syndrome (SARS)—associated coronavirus diagnostics (2025-06-10),

Company Overview

Institut Pasteur, located in Paris, France, is a leading research institution specializing in vaccine development and infectious diseases. The organization focuses on innovative technologies such as nucleic acid vaccines and immunogenic compositions, addressing critical health challenges including SARS-CoV-2 and malaria. Its research encompasses antibody neutralization, peptide inhibitors, and biological diagnostics, contributing significantly to global health advancements and the understanding of various pathogens.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

898 Patents

#14 in Paris

#29 in France

#1,132 in the World

Institut Pasteur

Forward Citations = 6,556

1,291 inventors:

Luc Montagnier (91 out of 112 patents)

Marc Alizon (53 out of 62 patents)

Pierre Sonigo (52 out of 63 patents)

4. Frédéric Tangy (36 out of 36 patents)

5. Pierre Charneau (35 out of 36 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Institut Pasteur. Retrieved from https://idiyas.com/company/institut-pasteur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…